3 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
Follow Bendamustine: new trials by email Literature Review of Bendamustine trials Research Report on Bendamustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma Bendamustine - Bendamustine, Multiple Myeloma | Phase 3 | Unknown | Liao Aijun | 10 | 2021-06-01 | 2021-08-16 |
| A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment Ofatumumab, Chlorambucil, Bendamustine - Chronic Lymphocytic Leukaemia | Phase 3 | Unknown | University of Liverpool | 670 | 2011-12-01 | 2012-10-15 |
| Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma Bendamustine - Non-Hodgkin Lymphoma by Clinical Course | Phase 3 | Unknown | Shandong Lanjin Pharmaceuticals Co.,Ltd | 100 | 2010-04-01 | 2012-08-02 |
Leukemia, B-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Liao Aijun (1) · Shandong Lanjin Pharmaceuticals Co.,Ltd (1) · University of Liverpool (1)
China (2) · United Kingdom (1)
Huaqing Wang, master (1) · Liao Aijun (1)